Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial‐mesenchymal transition in Panc‐1 and MiaPaCa‐2 pancreatic cancer cells
2019 ◽
Vol 121
(1)
◽
pp. 508-523
◽
2018 ◽
Vol 119
(7)
◽
pp. 5308-5323
◽
2014 ◽
2014 ◽
Vol 46
(3)
◽
pp. 1109-1120
◽
2015 ◽
Vol 13
(1)
◽
pp. 237-242
◽
2011 ◽
Vol 286
(12)
◽
pp. 10495-10504
◽
2013 ◽
Vol 228
(6)
◽
pp. 1255-1263
◽